Brief: Geneuro Confirms Top-Line Results In Its Post-Covid Trial By End-June
16/05/2024 07:03
May 16 (Reuters) - Geneuro SA GNRO.PA :
* GENEURO ANNOUNCES LAST PATIENT LAST VISIT IN ITS
POST-COVID
TRIAL AND CONFIRMS TOP-LINE RESULTS BY END OF JUNE 2024
Source text for Eikon: ID:nBw5bv5Ska
Further company coverage: GNRO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Geneuro SA
See all newsBrief: Geneuro SA Postpones Publication Of Half-Yearly Financial Report
Brief: Geneuro SA Announces Extension Of Its Definitive Debt-Restructuring Moratorium
Brief: Geneuro SA Announces The Opening Of Receivership Proceedings For Its French Subsidiary Geneuro Innovation Sas
Brief: Geneuro Confirms Top-Line Results In Its Post-Covid Trial By End-June
Brief: Geneuro announces EUR 5 Mln private placement